Clinical Trials Directory

Trials / Completed

CompletedNCT03230578

Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.

Detailed description

There are no studies examining New Mexico pharmacists' interest in prescribing hormonal contraceptives or rural New Mexican women's support for pharmacist prescribed hormonal contraceptives. However, some states where pharmacists already prescribe contraception have experienced difficulties in implementing the education, infrastructure, and financial support necessary to provide hormonal contraception in the community pharmacy setting. Nationwide, 68% of women reported that they would utilize pharmacist prescribed hormonal contraception and cited benefits such as convenient hours and locations of pharmacies. The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.

Conditions

Interventions

TypeNameDescription
OTHERPharmacists & women's perspectives on pharmacist prescribed hormonal contraceptionThe goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.

Timeline

Start date
2017-11-14
Primary completion
2018-06-08
Completion
2018-06-08
First posted
2017-07-26
Last updated
2018-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03230578. Inclusion in this directory is not an endorsement.